US20150297225A1

US20150297225A1 - Fastener cartridges including extensions having different configurations

Fastener cartridges including extensions having different configurations Download PDF

Info

Publication number: US20150297225A1
Authority: US; United States
Prior art keywords: staple; projections; deck; cartridge; tissue
Prior art date: 2014-04-16
Legal status : Abandoned

Application number

US14/734,376

Inventor

Thomas W. Huitema

Frederick E. Shelton, IV

Geoffrey C. Hueil

Jason L. Harris

Chester O. Baxter, III

Current Assignee

Cilag GmbH International

Original Assignee

Ethicon Endo Surgery Inc

Priority date

2014-04-16

Filing date

2015-06-09

Publication date

2015-10-22

2014-06-30 Priority claimed from US14/318,996 external-priority patent/US11517315B2/en

2015-06-09 Application filed by Ethicon Endo Surgery Inc filed Critical Ethicon Endo Surgery Inc

2015-06-09 Priority to US14/734,376 priority Critical patent/US20150297225A1/en

2015-09-23 Assigned to ETHICON ENDO-SURGERY, INC. reassignment ETHICON ENDO-SURGERY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAXTER, CHESTER O., III, SHELTON, FREDERICK E., IV, HARRIS, JASON L., HUEIL, GEOFFREY C., HUITEMA, THOMAS W.

2015-10-22 Publication of US20150297225A1 publication Critical patent/US20150297225A1/en

2016-01-15 Assigned to ETHICON ENDO-SURGERY, LLC reassignment ETHICON ENDO-SURGERY, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ETHICON ENDO-SURGERY, INC.

2017-03-03 Assigned to ETHICON LLC reassignment ETHICON LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ETHICON ENDO-SURGERY, LLC

2017-12-14 Assigned to ETHICON LLC reassignment ETHICON LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ETHICON ENDO-SURGERY, LLC

2020-04-03 Priority to US16/839,632 priority patent/US11963678B2/en

2020-06-16 Priority to US16/902,400 priority patent/US11717294B2/en

2021-04-27 Assigned to CILAG GMBH INTERNATIONAL reassignment CILAG GMBH INTERNATIONAL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ETHICON LLC

Status Abandoned legal-status Critical Current

Links

230000006835 compression Effects 0.000 claims description 12
238000007906 compression Methods 0.000 claims description 12
210000001519 tissue Anatomy 0.000 description 318
238000005520 cutting process Methods 0.000 description 150
238000010304 firing Methods 0.000 description 135
239000000463 material Substances 0.000 description 119
239000012636 effector Substances 0.000 description 103
239000002585 base Substances 0.000 description 57
230000033001 locomotion Effects 0.000 description 51
238000000034 method Methods 0.000 description 50
-1 for example Polymers 0.000 description 40
230000036961 partial effect Effects 0.000 description 38
230000008569 process Effects 0.000 description 23
102000008186 Collagen Human genes 0.000 description 13
108010035532 Collagen Proteins 0.000 description 13
229920001436 collagen Polymers 0.000 description 13
229920000642 polymer Polymers 0.000 description 12
239000000835 fiber Substances 0.000 description 10
230000014759 maintenance of location Effects 0.000 description 10
230000007704 transition Effects 0.000 description 9
230000000712 assembly Effects 0.000 description 8
238000000429 assembly Methods 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
238000005755 formation reaction Methods 0.000 description 8
229920003023 plastic Polymers 0.000 description 8
239000004033 plastic Substances 0.000 description 8
239000007787 solid Substances 0.000 description 8
229920001971 elastomer Polymers 0.000 description 7
239000013536 elastomeric material Substances 0.000 description 7
230000004044 response Effects 0.000 description 7
239000005060 rubber Substances 0.000 description 7
229920003031 santoprene Polymers 0.000 description 7
229920002725 thermoplastic elastomer Polymers 0.000 description 7
239000004020 conductor Substances 0.000 description 6
230000007423 decrease Effects 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
229920000954 Polyglycolide Polymers 0.000 description 5
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
230000008901 benefit Effects 0.000 description 5
238000010276 construction Methods 0.000 description 5
230000000994 depressogenic effect Effects 0.000 description 5
230000006870 function Effects 0.000 description 5
238000001746 injection moulding Methods 0.000 description 5
230000000670 limiting effect Effects 0.000 description 5
229920001610 polycaprolactone Polymers 0.000 description 5
230000005355 Hall effect Effects 0.000 description 4
239000004743 Polypropylene Substances 0.000 description 4
239000000853 adhesive Substances 0.000 description 4
230000001070 adhesive effect Effects 0.000 description 4
238000000576 coating method Methods 0.000 description 4
238000004891 communication Methods 0.000 description 4
238000006073 displacement reaction Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
238000003698 laser cutting Methods 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
150000003891 oxalate salts Chemical class 0.000 description 4
229920001281 polyalkylene Polymers 0.000 description 4
229920001155 polypropylene Polymers 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000007480 spreading Effects 0.000 description 4
238000003892 spreading Methods 0.000 description 4
229910001220 stainless steel Inorganic materials 0.000 description 4
239000010936 titanium Substances 0.000 description 4
229910052719 titanium Inorganic materials 0.000 description 4
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
102000016942 Elastin Human genes 0.000 description 3
108010014258 Elastin Proteins 0.000 description 3
102000009123 Fibrin Human genes 0.000 description 3
108010073385 Fibrin Proteins 0.000 description 3
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
108010049003 Fibrinogen Proteins 0.000 description 3
102000008946 Fibrinogen Human genes 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
208000032843 Hemorrhage Diseases 0.000 description 3
239000004952 Polyamide Substances 0.000 description 3
229920000331 Polyhydroxybutyrate Polymers 0.000 description 3
230000003213 activating effect Effects 0.000 description 3
229940030225 antihemorrhagics Drugs 0.000 description 3
230000008859 change Effects 0.000 description 3
238000004140 cleaning Methods 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
229960005188 collagen Drugs 0.000 description 3
230000000694 effects Effects 0.000 description 3
229920002549 elastin Polymers 0.000 description 3
229950003499 fibrin Drugs 0.000 description 3
229940012952 fibrinogen Drugs 0.000 description 3
239000006260 foam Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229940014259 gelatin Drugs 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
238000009434 installation Methods 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
239000007769 metal material Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000005015 poly(hydroxybutyrate) Substances 0.000 description 3
229920000747 poly(lactic acid) Polymers 0.000 description 3
229920002647 polyamide Polymers 0.000 description 3
229920000728 polyester Polymers 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
239000002861 polymer material Substances 0.000 description 3
229920002635 polyurethane Polymers 0.000 description 3
239000004814 polyurethane Substances 0.000 description 3
230000005855 radiation Effects 0.000 description 3
239000012858 resilient material Substances 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
230000000087 stabilizing effect Effects 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
229920001661 Chitosan Polymers 0.000 description 2
239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
108010076876 Keratins Proteins 0.000 description 2
102000011782 Keratins Human genes 0.000 description 2
229920002201 Oxidized cellulose Polymers 0.000 description 2
229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
229920001710 Polyorthoester Polymers 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
230000006978 adaptation Effects 0.000 description 2
229920003232 aliphatic polyester Polymers 0.000 description 2
229910045601 alloy Inorganic materials 0.000 description 2
239000000956 alloy Substances 0.000 description 2
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
239000002260 anti-inflammatory agent Substances 0.000 description 2
229940121363 anti-inflammatory agent Drugs 0.000 description 2
239000004599 antimicrobial Substances 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
239000000560 biocompatible material Substances 0.000 description 2
230000000740 bleeding effect Effects 0.000 description 2
229920001400 block copolymer Polymers 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
229920003064 carboxyethyl cellulose Polymers 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000000748 compression moulding Methods 0.000 description 2
229920001577 copolymer Polymers 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 2
238000009950 felting Methods 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
150000002314 glycerols Chemical class 0.000 description 2
230000000025 haemostatic effect Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
239000002874 hemostatic agent Substances 0.000 description 2
229920001519 homopolymer Polymers 0.000 description 2
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
239000001863 hydroxypropyl cellulose Substances 0.000 description 2
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000009940 knitting Methods 0.000 description 2
238000003754 machining Methods 0.000 description 2
229910044991 metal oxide Inorganic materials 0.000 description 2
150000004706 metal oxides Chemical class 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
238000000465 moulding Methods 0.000 description 2
239000005445 natural material Substances 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
229940107304 oxidized cellulose Drugs 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
229920009441 perflouroethylene propylene Polymers 0.000 description 2
229920001308 poly(aminoacid) Polymers 0.000 description 2
229920002627 poly(phosphazenes) Polymers 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
239000004584 polyacrylic acid Substances 0.000 description 2
239000004632 polycaprolactone Substances 0.000 description 2
229920001343 polytetrafluoroethylene Polymers 0.000 description 2
239000004810 polytetrafluoroethylene Substances 0.000 description 2
229920002451 polyvinyl alcohol Polymers 0.000 description 2
235000019422 polyvinyl alcohol Nutrition 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
229910052705 radium Inorganic materials 0.000 description 2
HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 2
239000011435 rock Substances 0.000 description 2
239000011343 solid material Substances 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
230000003068 static effect Effects 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
238000004659 sterilization and disinfection Methods 0.000 description 2
229920002994 synthetic fiber Polymers 0.000 description 2
BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 2
229920001169 thermoplastic Polymers 0.000 description 2
229920001187 thermosetting polymer Polymers 0.000 description 2
238000012795 verification Methods 0.000 description 2
238000009941 weaving Methods 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical class NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000013641 Cerebrofacial arteriovenous metameric syndrome Diseases 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
229920001651 Cyanoacrylate Polymers 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
229920001612 Hydroxyethyl starch Polymers 0.000 description 1
229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
229920000106 Liquid crystal polymer Polymers 0.000 description 1
239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
229920001207 Noryl Polymers 0.000 description 1
239000004727 Noryl Substances 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000007327 Protamines Human genes 0.000 description 1
108010007568 Protamines Proteins 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
239000004775 Tyvek Substances 0.000 description 1
229920000690 Tyvek Polymers 0.000 description 1
229920004738 ULTEM® Polymers 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
239000002313 adhesive film Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229940037003 alum Drugs 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical class [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
229960002684 aminocaproic acid Drugs 0.000 description 1
108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
208000034158 bleeding Diseases 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000000621 bronchi Anatomy 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
229940059329 chondroitin sulfate Drugs 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
WCOATMADISNSBV-UHFFFAOYSA-K diacetyloxyalumanyl acetate Chemical class [Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WCOATMADISNSBV-UHFFFAOYSA-K 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000012976 endoscopic surgical procedure Methods 0.000 description 1
HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
230000006203 ethylation Effects 0.000 description 1
238000006200 ethylation reaction Methods 0.000 description 1
229940032950 ferric sulfate Drugs 0.000 description 1
238000007667 floating Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000002439 hemostatic effect Effects 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
229940050526 hydroxyethylstarch Drugs 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
238000012830 laparoscopic surgical procedure Methods 0.000 description 1
229910001416 lithium ion Inorganic materials 0.000 description 1
230000036244 malformation Effects 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
229960002160 maltose Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000013011 mating Effects 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000008520 organization Effects 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
229920000233 poly(alkylene oxides) Polymers 0.000 description 1
229920000117 poly(dioxanone) Polymers 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920006393 polyether sulfone Polymers 0.000 description 1
229920001601 polyetherimide Polymers 0.000 description 1
229920002959 polymer blend Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
229950008679 protamine sulfate Drugs 0.000 description 1
238000011084 recovery Methods 0.000 description 1
239000004627 regenerated cellulose Substances 0.000 description 1
238000004353 relayed correlation spectroscopy Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
230000035322 succinylation Effects 0.000 description 1
238000010613 succinylation reaction Methods 0.000 description 1
229910000811 surgical stainless steel Inorganic materials 0.000 description 1
239000010966 surgical stainless steel Substances 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
229920001864 tannin Polymers 0.000 description 1
239000001648 tannin Substances 0.000 description 1
235000018553 tannin Nutrition 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
229910052720 vanadium Inorganic materials 0.000 description 1
GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
239000005526 vasoconstrictor agent Substances 0.000 description 1
238000004804 winding Methods 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1